EMEA-001366-PIP01-12-M02
Key facts
Invented name |
Sialanar
|
Active substance |
Glycopyrronium bromide
|
Therapeutic area |
Neurology
|
Decision number |
P/0240/2014
|
PIP number |
EMEA-001366-PIP01-12-M02
|
Pharmaceutical form(s) |
Oral liquid
|
Condition(s) / indication(s) |
Treatment of sialorrhoea
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Proveca Limited
E-mail: simon@proveca.co.uk |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001366-PIP01-12-M02
|
Compliance opinion date |
14/11/2014
|
Compliance outcome |
positive
|